Wheels of Justice Turning for Victims of Vision Loss from Elmiron Drug
Those of you who have been following us here at The Yost Legal Group as clients or regular readers know we have remained at the forefront of the Elmiron litigation. We write about it regularly. For our new readers, however, here is a quick recap.
Elmiron is the only pill-based drug approved by the United States Food and Drug Administration (FDA) to treat interstitial cystitis (IC), an enigmatic, chronic-pain condition that affects the bladder and pelvic wall.
Interstitial cystitis can be quite painful and debilitating for people, affecting them in every facet of their lives. Unfortunately, the only approved medication to treat IC at this time is Elmiron (pentosan polysulfate sodium), which science has credibly linked to vision loss. In fact, prior to people’s taking Elmiron, the form of vision loss (specifically known as macular degeneration) found in Elmiron users had never been observed before.
Now, as of July 2022, there are over 1,300 pending cases for the Elmiron multi-district litigation, which resides in the U.S. District Court for New Jersey under Judge Brian Martinotti.
Plaintiffs claim the manufacturer of Elmiron, Jansen Pharmaceuticals, knowingly withheld information from the FDA, medical professionals, and potential users regarding the connection between long-term use (minimum of two years) of the defective drug and the potential to develop lifelong eye conditions.
Long-term use of Elmiron has been liked to the following eye conditions:
• Blurred vision
• Dark spots in field of vision
• Macular degeneration
• Pigmentary maculopathy
Supporting evidence from research has shown such a distinct connection between the long-term use of Elmiron and pigmentary maculopathy that the medical community now acknowledges the phenomenon as factual.
As the Elmiron MDL continues to grow, attorneys for both parties are submitting fact sheets, claim forms, and conferring to discuss discovery issues, trial dates, and Bellweather cases.
“Bellweather cases” are test-trial cases used to represent the entire MDL before all other trials are held. Think of them as the “canary in the coal mine.” The first Bellwether case is tentatively scheduled for January 2023.
If you or a loved one has suffered from vision loss after long-term use of Elmiron, please contact one The Yost Legal Group’s Elmiron specialists at 1-800-YOST-LAW. We will seek the justice you deserve.